The effect of enzyme inhibitor and absorption site following [D-ala2,D-leu5]enkephalin oral administration in rats
- 9 May 2002
- journal article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 23 (4) , 131-141
- https://doi.org/10.1002/bdd.302
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Factors and strategies for improving buccal absorption of peptidesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- Transmucosal delivery systems for calcitonin: a reviewBiomaterials, 2000
- First-pass Metabolism of Peptide Drugs in Rat Perfused LiverJournal of Pharmacy and Pharmacology, 1998
- Intranasal drug deliveryAdvanced Drug Delivery Reviews, 1998
- A month–long effect from a single injection of microencapsulated human growth hormoneNature Medicine, 1996
- Percutaneous Absorption and Dermal Delivery of Cyclosporin AJournal of Pharmaceutical Sciences, 1995
- Absorption of Peptide and Peptidomimetic DrugsAnnual Review of Pharmacology and Toxicology, 1994
- Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated CompoundsPharmaceutical Research, 1988
- Postsecretory Metabolism of PeptidesAmerican Review of Respiratory Disease, 1987
- Absorption of Insulin from the Human Small IntestineDiabetes, 1968